Company profile
HOME - Antibody Production - Monoclonal - Polyclonal
A leading provider for flexible and professional contract development of quality antibodies both monoclonal and polyclonal.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ0MDA1MjQ5MGFkaXF6a2N4
Published 18 Oct 2024 09:47
Company registered at Companies House
1 Jan 2024 to 31 Mar 2026
Life Science Group (LSG), in partnership with Aberystwyth University (AU), Highfield Diagnostics (HDx), Protem Services (PS) and Valley Diagnostics (VDX) and Professor Keir Lewis, a respiratory specialist at Hywel Dda University Health Board (HDUHB), are developing a rapid, cost-effective diagnostic kit using a digital platform for the early detection of ...
1 Jun 2020 to 28 Feb 2021
Current Covid-19 testing of patient samples follows guidelines published by the World Health Organisation (WHO), which have been followed by health organisations in developed countries such as the National Health Service in the UK and Centre for Disease Control (CDC) in the USA. These protocols all transport virus 'live' in a cell preservation media that ...
1 Feb 2018 to 31 May 2021
To develop a new defined serum-free media for cell culture and storage to replace undefined media containing animal-serum, therefore preventing batch variation and contamination, and conforming to the legal requirements of the updated Animal (Scientific Procedures) Act.
